- Home
- Supplements
- Luteolin
Luteolin
TL;DR
Luteolin is a plant flavone with strong anti-inflammatory and mast-cell-stabilising activity in the lab. Human trials are few and small, mostly in autism and brain fog formulas combined with other flavonoids.
Ideal For
- People with mast cell activation symptoms exploring adjuncts alongside antihistamines
- Those researching neuroinflammation-related brain fog under clinician guidance
Avoid If
- You are pregnant or breastfeeding
- You take drugs metabolised by CYP enzymes without checking interactions
- You have a known allergy to Asteraceae plants such as chamomile
Frequently Asked Questions
What is luteolin?
What is the evidence in humans?
What dose is used?
Is absorption an issue?
Does it help brain fog or mast cell activation?
Is it safe?
Overview
Luteolin occurs in celery, parsley, chamomile, thyme and green pepper, and it has become one of the more heavily studied flavones in neuroinflammation research. In cell and animal models it inhibits mast cell degranulation, suppresses microglial activation, and blocks IL-6, TNF-alpha and NF-kB signalling — a coherent package that explains its appearance in "brain fog", histamine intolerance and long-COVID formulas. The human evidence is much thinner than the preclinical volume suggests. The most cited trials come from Theoharides' group, using a luteolin-plus-quercetin formulation in children with autism spectrum disorder, where open-label and small controlled work reported improvements in social communication scores. There is also small work in mastocytosis-related brain fog. What does not exist is a large, independent, placebo-controlled trial of luteolin alone for any condition. Bioavailability is the practical constraint: free luteolin is poorly absorbed and extensively glucuronidated, which is why liposomal and olive-oil-suspended preparations dominate the market. Treat luteolin as mechanistically compelling and clinically unproven.
How It Works
- Stabilises mast cells, reducing histamine, tryptase and IL-6 release
- Inhibits microglial activation and pro-inflammatory cytokine production in the CNS
- Suppresses NF-kB signalling, the master switch for inflammatory gene transcription
- Inhibits PDE4 and acts as an antioxidant scavenging reactive oxygen species
Benefits & Outcomes
No linked outcomes yet. Research is ongoing.
Supporting Research4 studies
Luteolin as an anti-inflammatory and neuroprotective agent: A brief review
Nabavi SF, Braidy N, Gortzi O
Luteolin inhibits NF-kB signalling and mast cell activation in preclinical models, with human clinical evidence still very limited.
Intestinal absorption of luteolin and luteolin 7-O-beta-glucoside in rats and humans
Shimoi K, Okada H, Furugori M
Orally administered luteolin circulates largely as glucuronide conjugates with limited free luteolin.
Serenoa repens associated with Urtica dioica (ProstaMEV) and curcumin and quercitin (FlogMEV) extracts are able to improve the efficacy of prulifloxacin in bacterial prostatitis patients: results from a prospective randomised study
Cai T, Mazzoli S, Bechi A
Adding a luteolin-containing flavonoid formulation to antibiotics improved symptom scores in chronic prostatitis.
A case series of a luteolin formulation (NeuroProtek®) in children with autism spectrum disorders
Theoharides TC, Asadi S, Panagiotidou S
A luteolin-quercetin formulation was associated with improved communication scores in children with autism in an uncontrolled study.
Safety Information
Potential Side Effects
Generally well tolerated. Reported effects include GI upset, headache and occasional irritability, particularly in the paediatric formulation studies.
Contraindications
Pregnancy and lactation due to absent safety data.
Drug Interactions
- May inhibit CYP1A2, CYP2C9 and CYP3A4, potentially raising levels of drugs cleared by these enzymes
- Theoretical additive effect with antiplatelet drugs
Pregnancy & Breastfeeding
Pregnancy: Not enough evidence to judge
Breastfeeding: Not enough evidence to judge
Dosage Guidelines
Dosage Used in Studies
Consult healthcare provider
Dosing by Goal
| Goal | Dose | Notes |
|---|---|---|
| Typical | 100-300 mg daily | |
| Research formulations | Roughly 100 mg per 10 kg body weight daily in the paediatric autism studies | |
| Notes | Take with fat to improve absorption |
Forms Compared
Liposomal luteolin
Improves the poor oral bioavailability of free luteolin
Luteolin in olive oil suspension
Format used in the autism research formulations
Standard capsules
Cheapest but least absorbable
Combined with quercetin/rutin
How most of the human trial products were formulated
Food & Timing
With a fat-containing meal; flavone absorption improves substantially with dietary lipid.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.